Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma

被引:34
作者
Ishida, T [1 ]
机构
[1] Mie Univ, Sch Med, Dept Surg 2, Tsu, Mie 5148507, Japan
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 2000年 / 30卷 / 01期
关键词
CD44; variant; 6; colorectal carcinoma; immunohistochemistry;
D O I
10.1007/PL00010042
中图分类号
R61 [外科手术学];
学科分类号
摘要
The CD44 variant 6 (CD44 v6) has been postulated to be involved in both carcinogenesis and tumor progression. In the present study, CD44 v6 was stained immunohistochemically in 63 colorectal cancer tissues to assess significance of CD44 v6 in the carcinogenesis and progression of colorectal carcinoma. None of the normal colonocytes showed an expression of CD44 v6, CD44 v6 expression was very strong in 24, moderate in 13, and negative in 26 tumor tissues. A negative or moderate expression of CD44 v6 was significantly associated with a larger tumor size (P < 0.05) and invasion through the bowel wall (P < 0.01). There was no correlation between the expression of CD44 v6 and gross type, histologic differentiation, lymph node involvement, liver metastasis, and clinical stage of the disease. The present study showed that the expression of CD44 v6 was characteristic of neoplastic changes in the colonocytes and that a diminished expression of CD44 v6 was associated with the penetration of colorectal cancer through the bowel wall, but not with either lymph node or distant metastasis.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 29 条
[1]   THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM [J].
ASTLER, VB ;
COLLER, FA .
ANNALS OF SURGERY, 1954, 139 (06) :846-852
[2]   CD44V6 expression in human colorectal carcinoma [J].
Coppola, D ;
Hyacinthe, M ;
Fu, L ;
Cantor, AB ;
Karl, R ;
Marcet, J ;
Cooper, DL ;
Nicosia, SV ;
Cooper, HS .
HUMAN PATHOLOGY, 1998, 29 (06) :627-635
[3]  
Finke LH, 1996, ZBL CHIR, V121, P450
[4]  
Furuta K, 1998, CLIN CANCER RES, V4, P21
[5]   Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer [J].
Gotley, DC ;
Fawcett, J ;
Walsh, MD ;
Reeder, JA ;
Simmons, DL ;
Antalis, TM .
BRITISH JOURNAL OF CANCER, 1996, 74 (03) :342-351
[6]  
GUNTHERT U, 1995, CANCER SURV, V24, P19
[7]   A HUMAN HOMOLOG OF THE RAT METASTASIS-ASSOCIATED VARIANT OF CD44 IS EXPRESSED IN COLORECTAL CARCINOMAS AND ADENOMATOUS POLYPS [J].
HEIDER, KH ;
HOFMANN, M ;
HORS, E ;
VANDENBERG, F ;
PONTA, H ;
HERRLICH, P ;
PALS, ST .
JOURNAL OF CELL BIOLOGY, 1993, 120 (01) :227-233
[8]   CD44 IN COLON-CANCER [J].
HERRLICH, P ;
PALS, S ;
PONTA, H .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) :1110-1112
[9]   USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) :577-580
[10]   POSITIVE RELATIONSHIP BETWEEN EXPRESSION OF CD44 AND HEPATIC METASTASES IN COLORECTAL-CANCER [J].
ICHIKAWA, W .
PATHOBIOLOGY, 1994, 62 (04) :172-179